235 related articles for article (PubMed ID: 28859365)
1. Incidence of brain metastasis from esophageal cancer.
Welch G; Ross HJ; Patel NP; Jaroszewski DE; Fleischer DE; Rule WG; Paripati HR; Ramirez FC; Ashman JB
Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859365
[TBL] [Abstract][Full Text] [Related]
2. Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.
Anghel R; Constantinoiu S; Bacinschi X; Gales L; Toma RV; Trifanescu O
Chirurgia (Bucur); 2018; 113(1):116-122. PubMed ID: 29509538
[No Abstract] [Full Text] [Related]
3. Incidence of brain metastasis in patients with esophageal carcinoma.
Smith RS; Miller RC
World J Gastroenterol; 2011 May; 17(19):2407-10. PubMed ID: 21633640
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases from esophageal cancer: clinical review of 26 cases.
Song Z; Lin B; Shao L; Zhang Y
World Neurosurg; 2014 Jan; 81(1):131-5. PubMed ID: 23435161
[TBL] [Abstract][Full Text] [Related]
5. Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience.
Sio TT; Wilson ZC; Stauder MC; Bhatia S; Martenson JA; Quevedo JF; Schomas DA; Miller RC
Am J Clin Oncol; 2016 Oct; 39(5):448-52. PubMed ID: 24879469
[TBL] [Abstract][Full Text] [Related]
6. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
7. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical management of esophageal adenocarcinoma.
Gujral DM; Hawkins MA; Leonulli BG; Ashley S; Chau I; Cunningham D; Tait D
Clin Colorectal Cancer; 2011 Sep; 10(3):165-70. PubMed ID: 21855037
[TBL] [Abstract][Full Text] [Related]
9. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
González Ortiz DI; Toro DH
Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
[TBL] [Abstract][Full Text] [Related]
10. The prognostic factors influencing overall survival in uterine cervical cancer with brain metastasis.
Kim H; Lee KK; Heo MH; Kim JY
Korean J Intern Med; 2019 Nov; 34(6):1324-1332. PubMed ID: 30360020
[TBL] [Abstract][Full Text] [Related]
11. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
12. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
13. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
15. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
Wang J; Suri JS; Allen PK; Liao Z; Komaki R; Ho L; Hofstetter WL; Lin SH
Am J Clin Oncol; 2016 Jun; 39(3):228-35. PubMed ID: 24710122
[TBL] [Abstract][Full Text] [Related]
16. Metastasis of esophageal carcinoma to the brain.
Weinberg JS; Suki D; Hanbali F; Cohen ZR; Lenzi R; Sawaya R
Cancer; 2003 Nov; 98(9):1925-33. PubMed ID: 14584076
[TBL] [Abstract][Full Text] [Related]
17. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; van Laarhoven HW; Hulshof MC
Acta Oncol; 2017 Jan; 56(1):33-38. PubMed ID: 27842455
[TBL] [Abstract][Full Text] [Related]
18. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
19. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
Yomo S; Hayashi M
BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
[TBL] [Abstract][Full Text] [Related]
20. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
